186 related articles for article (PubMed ID: 1457369)
21. [Chemotherapeutic strategy in rat brain tumor cells resistant to ACNU using an in vitro colony formation assay].
Mineura K; Sasaki J; Fushimi S; Sasajima H; Ishino Y; Kowada M
No To Shinkei; 1989 Sep; 41(9):927-32. PubMed ID: 2590562
[TBL] [Abstract][Full Text] [Related]
22. Cross-resistance pattern in brain tumour cells resistant to antitumour chloroethylnitrosoureas.
Mineura K; Ishiyama Y; Kowada M
Neurol Res; 1992 Mar; 14(1):45-8. PubMed ID: 1351258
[TBL] [Abstract][Full Text] [Related]
23. Development of experimental meningeal gliomatosis models in rats.
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Arita N; Mogami H
J Neurosurg; 1986 Oct; 65(4):503-7. PubMed ID: 3760960
[TBL] [Abstract][Full Text] [Related]
24. Development of resistance to antitumor chloroethylnitrosoureas in vitro in brain tumor cells.
Mineura K; Ishiyama Y; Kowada M
Acta Oncol; 1992; 31(7):755-9. PubMed ID: 1476755
[TBL] [Abstract][Full Text] [Related]
25. Potential of O6-methylguanine or O6-benzylguanine in the enhancement of chloroethylnitrosourea cytotoxicity on brain tumours.
Mineura K; Izumi I; Watanabe K; Kowada M; Kohda K; Ikenaga M
Acta Neurochir (Wien); 1994; 128(1-4):13-20. PubMed ID: 7847129
[TBL] [Abstract][Full Text] [Related]
26. [Chemotherapy of experimental meningeal gliomatosis].
Yoshida T; Ushio Y; Hayakawa T; Shimizu K; Mogami H; Nakata Y; Sakamoto Y
Neurol Med Chir (Tokyo); 1984 May; 24(5):302-8. PubMed ID: 6206412
[No Abstract] [Full Text] [Related]
27. Convection-enhanced delivery of a hydrophilic nitrosourea ameliorates deficits and suppresses tumor growth in experimental spinal cord glioma models.
Ogita S; Endo T; Sugiyama S; Saito R; Inoue T; Sumiyoshi A; Nonaka H; Kawashima R; Sonoda Y; Tominaga T
Acta Neurochir (Wien); 2017 May; 159(5):939-946. PubMed ID: 28247160
[TBL] [Abstract][Full Text] [Related]
28. Significance of DNA cross-links on 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3- nitrosourea (ACNU)-induced cytotoxicity against ACNU-sensitive and -resistant lines of 9L rat glioma cells.
Kokunai T; Tamaki N; Matsumoto S
J Natl Cancer Inst; 1987 Jul; 79(1):119-22. PubMed ID: 3474438
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of a rat meningeal gliomatosis model with neocarzinostatin].
Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y; Egawa T
No To Shinkei; 1987 Jul; 39(7):615-9. PubMed ID: 2960332
[TBL] [Abstract][Full Text] [Related]
30. Interrelationship between O6-alkylguanine-DNA alkyltransferase activity and susceptibility to chloroethylnitrosoureas in several glioma cell lines.
Hotta T; Saito Y; Mikami T; Kurisu K; Kiya K; Uozumi T; Isowa G; Ishizaki K; Ikenaga M
J Neurooncol; 1993 Jul; 17(1):1-8. PubMed ID: 8120566
[TBL] [Abstract][Full Text] [Related]
31. Alteration of blood-CSF barrier by tumor invasion into the meninges.
Ushio Y; Shimizu K; Aragaki Y; Arita N; Hayakawa T; Mogami H
J Neurosurg; 1981 Sep; 55(3):445-9. PubMed ID: 6943305
[TBL] [Abstract][Full Text] [Related]
32. Acquisition of resistance to antitumor alkylating agent ACNU: a possible target of positron emission tomography monitoring.
Kawai H; Toyohara J; Kado H; Nakagawa T; Takamatsu S; Furukawa T; Yonekura Y; Kubota T; Fujibayashi Y
Nucl Med Biol; 2006 Jan; 33(1):29-35. PubMed ID: 16459256
[TBL] [Abstract][Full Text] [Related]
33. [Intrathecal perfusion of ACNU neurotoxicity and intrathecal pharmacokinetics in dogs].
Kochi M; Kuratsu J; Mihara Y; Inoue N; Takaki S; Sueyoshi N; Soyama N; Uemura S; Ushio Y
No Shinkei Geka; 1989 Aug; 17(8):741-6. PubMed ID: 2586715
[TBL] [Abstract][Full Text] [Related]
34. Intrathecal ACNU treatment of B16 melanoma leptomeningeal metastasis in a new athymic rat model.
Schabet M; Ohneseit P; Buchholz R; Santo-Höltje L; Schmidberger H
J Neurooncol; 1992 Oct; 14(2):169-75. PubMed ID: 1432039
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
Sugiyama S; Yamashita Y; Kikuchi T; Saito R; Kumabe T; Tominaga T
J Neurooncol; 2007 Mar; 82(1):41-7. PubMed ID: 17031554
[TBL] [Abstract][Full Text] [Related]
36. Phase I/II study of intraventricular and intrathecal ACNU for leptomeningeal neoplasia.
Levin VA; Chamberlain M; Silver P; Rodriguez L; Prados M
Cancer Chemother Pharmacol; 1989; 23(5):301-7. PubMed ID: 2706735
[TBL] [Abstract][Full Text] [Related]
37. ACNU-resistant mutants of 9L rat glioma cell line. Isolation and preliminary characterization of these subclones.
Kokunai T; Tamaki N; Matsumoto S
J Neurosurg; 1985 Oct; 63(4):583-8. PubMed ID: 3861792
[TBL] [Abstract][Full Text] [Related]
38. [Chemotherapy for experimental subarachnoid dissemination model of brain tumor].
Yamashita T; Shinonaga M; Ishiwata Y; Nishimura S; Murai M; Kyuma Y; Kuwabara T
No Shinkei Geka; 1984 Jan; 12(1):47-53. PubMed ID: 6585681
[TBL] [Abstract][Full Text] [Related]
39. Effects of high-dose chemotherapy with syngeneic bone marrow transplantation in experimental brain tumor in rats.
Soma M; Shoin K; Yamashita J
Cancer; 1993 Jan; 71(2):364-9. PubMed ID: 8422630
[TBL] [Abstract][Full Text] [Related]
40. Isolation and preliminary characterization of ACNU-resistant sublines of rat brain tumors in vivo.
Yoshida TK; Shimizu K; Koulousakis A; Sturm V; Beuls E
J Neurosurg; 1992 Sep; 77(3):451-6. PubMed ID: 1506893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
